CSL Behring News

CSL Behring News

red text csl behring logo

First SCIg Approved for CIDP

HIZENTRA, the First Subcutaneous Immunoglobulin (SCIg) Approved for CIDP

17 Sep 2018 Company
World Haemophilia Day

World Haemophilia Day

CSL Behring Marks World Haemophilia Day by Shipping Bleeding Disorders Medicines to t…

17 Apr 2018 Company
Broadmeadows research scientist

Patient Enrolled in CSL112 Clinical Trial

The AEGIS-II trial will enrol more than 17,000 patients from approximately 1,000 medi…

23 Mar 2018 Company
Forbes Global World's Best Employers Logo

Making Forbes’ Top Global Employers List

Global biotech leader rated at no. 42 for patient focus, innovation and sustainable g…

20 Mar 2018 Company
Aerial view of CSL Berhing Australia Broadmeadows site

New National Fractionation Agreement

CSL Behring today announced that it has signed an agreement with the National Blood A…

11 Dec 2017 Company